Skip to main content
. 2020 May 20;34(1):102–111. doi: 10.1007/s12028-020-00986-4

Fig. 1.

Fig. 1

Responder status according to neurostimulant administered. Responder status according to neurostimulant administered (i.e., amantadine, modafinil, or both) on the day responder status was first documented is reported. Of the 42 responders, 34 (81%) were receiving amantadine monotherapy and 8 (19%) were receiving both amantadine and modafinil (p < 0.001). Patients receiving modafinil monotherapy were never classified as responders